Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    7 August 2022

    • curprev 01:4901:49, 7 August 2022‎ 179.215.124.0 talk‎ 569 bytes +569‎ Created page with "== Target Article == Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy; LM Xu, H Fang, WH Wang, J Jin, SL Wangae; 2013; doi_citing_unknown == Retraction == RETRACTED: Development and Validation of a New Outcome Score in Subglottic Stenosis; Gonfiotti, Alessandro; Jaus, Massimo Osvaldo; Barale, Daniel; Baiguera, Silvia; Polizzi, Leonardo; J; 2012-10-01 ; https://d..."
Retrieved from "https://wikicitingretracted.org/index.php?title=Prognostic_significance_of_rituximab_and_radiotherapy_for_patients_with_primary_mediastinal_large_B-cell_lymphoma_receiving_doxorubicin-containing_chemotherapy"